Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone

BACKGROUND: Vascular disease burden after lower extremity revascularization (LER) comprises more than the first event, more vascular beds than the local arteries, and more than one clinical event type. OBJECTIVES: Assess total arterial and venous thrombotic burden after LER for symptomatic periphera...

Descripción completa

Detalles Bibliográficos
Autores principales: Berkowitz, Scott D., Bauersachs, Rupert M., Szarek, Michael, Nehler, Mark R., Debus, E. Sebastian, Patel, Manesh R., Anand, Sonia S., Capell, Warren H., Hess, Connie N., Hsia, Judy, Leeper, Nicholas J., Brasil, David, Mátyás, Lajos, Diaz, Rafael, Brodmann, Marianne, Muehlhofer, Eva, Haskell, Lloyd P., Bonaca, Marc P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
THROMBOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314576/
https://www.ncbi.nlm.nih.gov/pubmed/35170216
http://dx.doi.org/10.1111/jth.15673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314576/
https://www.ncbi.nlm.nih.gov/pubmed/35170216
http://dx.doi.org/10.1111/jth.15673

Ejemplares similares